Welcome to the HIV/AIDS Prevention Research Division
The mission of the HIV/AIDS Prevention Research Division is to develop and evaluate interventions designed to reduce the spread of HIV and other blood-borne infections. The division promotes the application of evidence-based practices in the development of public health policies to respond to the HIV epidemic.
News
Clinical trial to test immune modulation strategy for hospitalized covid-19 patients begins
09/22/23Part of NIH’s STRIVE consortium, the therapeutic may prevent overactive immune systems from causing severe symptoms.
Researchers develop new method to identify potential stroke therapies
09/20/23First-of-its-kind study points to uric acid as a promising treatment for further investigation.
Researchers discover biomarker for tracking depression recovery
09/20/23New deep brain stimulation device coupled with powerful AI may improve therapy for treatment-resistant depression.
Clinical trial of HIV vaccine begins in United States and South Africa
09/20/23Novel vaccine includes NIH-funded technology in development since 2004.
Higher buprenorphine doses associated with improved retention in treatment for opioid use disorder
09/18/23NIH-funded study suggests need to reevaluate opioid addiction treatment recommendations in the era of fentanyl.